CHAMPIONS ONCOLOGY INC (CSBR) Stock Overview
NASDAQ:CSBR - US15870P3073 - Common Stock
CSBR Key Statistics, Chart & Performance
The current stock price of CSBR is 6.85 USD. In the past month the price increased by 11.95%. In the past year, price increased by 60.94%.
CSBR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 22.15 | 183.10B | ||
| DHR | DANAHER CORP | 26.21 | 141.33B | ||
| A | AGILENT TECHNOLOGIES INC | 23.49 | 36.37B | ||
| IQV | IQVIA HOLDINGS INC | 16.3 | 31.77B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.88 | 26.86B | ||
| WAT | WATERS CORP | 25.15 | 18.31B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 36.38 | 18.21B | ||
| ILMN | ILLUMINA INC | 23.49 | 15.02B | ||
| TEM | TEMPUS AI INC | N/A | 14.13B | ||
| ICLR | ICON PLC | 13.49 | 13.88B | ||
| MEDP | MEDPACE HOLDINGS INC | 36.4 | 13.75B | ||
| QGEN | QIAGEN N.V. | 20.24 | 10.31B |
Related stock screener links
About CSBR
Company Profile
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Company Info
CHAMPIONS ONCOLOGY INC
One University Plaza,, Suite 307
Hackensack NEW JERSEY 07601 US
CEO: Ronnie Morris
Employees: 210
Phone: 12018088400
CHAMPIONS ONCOLOGY INC / CSBR FAQ
What is the stock price of CHAMPIONS ONCOLOGY INC today?
The current stock price of CSBR is 6.85 USD. The price increased by 0.15% in the last trading session.
What is the ticker symbol for CHAMPIONS ONCOLOGY INC stock?
The exchange symbol of CHAMPIONS ONCOLOGY INC is CSBR and it is listed on the Nasdaq exchange.
On which exchange is CSBR stock listed?
CSBR stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CHAMPIONS ONCOLOGY INC stock?
7 analysts have analysed CSBR and the average price target is 12.24 USD. This implies a price increase of 78.69% is expected in the next year compared to the current price of 6.85. Check the CHAMPIONS ONCOLOGY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CHAMPIONS ONCOLOGY INC worth?
CHAMPIONS ONCOLOGY INC (CSBR) has a market capitalization of 94.46M USD. This makes CSBR a Micro Cap stock.
How many employees does CHAMPIONS ONCOLOGY INC have?
CHAMPIONS ONCOLOGY INC (CSBR) currently has 210 employees.
What are the support and resistance levels for CHAMPIONS ONCOLOGY INC (CSBR) stock?
CHAMPIONS ONCOLOGY INC (CSBR) has a support level at 6.81 and a resistance level at 7.2. Check the full technical report for a detailed analysis of CSBR support and resistance levels.
Is CHAMPIONS ONCOLOGY INC (CSBR) expected to grow?
The Revenue of CHAMPIONS ONCOLOGY INC (CSBR) is expected to grow by 7.8% in the next year. Check the estimates tab for more information on the CSBR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CHAMPIONS ONCOLOGY INC (CSBR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CSBR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CSBR, evaluating the profitability, health, valuation and growth aspects
- CHAMPIONS ONCOLOGY INC (CSBR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CHAMPIONS ONCOLOGY INC (CSBR) Sales and EPS estimates to see what analysts future expectations are.
- CHAMPIONS ONCOLOGY INC (CSBR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CHAMPIONS ONCOLOGY INC (CSBR) Insider and Institutional Ownership to learn about the owners and their transactions.
- CHAMPIONS ONCOLOGY INC (CSBR) Stock Chart to make your own analysis
- CHAMPIONS ONCOLOGY INC (CSBR) Latest news and press-releases to stay up to date.
Does CHAMPIONS ONCOLOGY INC (CSBR) stock pay dividends?
CSBR does not pay a dividend.
When does CHAMPIONS ONCOLOGY INC (CSBR) report earnings?
CHAMPIONS ONCOLOGY INC (CSBR) will report earnings on 2025-09-10.
What is the Price/Earnings (PE) ratio of CHAMPIONS ONCOLOGY INC (CSBR)?
The PE ratio for CHAMPIONS ONCOLOGY INC (CSBR) is 15.22. This is based on the reported non-GAAP earnings per share of 0.45 and the current share price of 6.85 USD. Check the full fundamental report for a full analysis of the valuation metrics for CSBR.
What is the Short Interest ratio of CHAMPIONS ONCOLOGY INC (CSBR) stock?
The outstanding short interest for CHAMPIONS ONCOLOGY INC (CSBR) is 0.93% of its float. Check the ownership tab for more information on the CSBR short interest.
CSBR Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to CSBR. When comparing the yearly performance of all stocks, CSBR is one of the better performing stocks in the market, outperforming 85.08% of all stocks.
CSBR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to CSBR. CSBR has an average financial health and profitability rating.
CSBR Financial Highlights
Over the last trailing twelve months CSBR reported a non-GAAP Earnings per Share(EPS) of 0.45. The EPS increased by 191.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.26% | ||
| ROA | 14.53% | ||
| ROE | 124.63% | ||
| Debt/Equity | 0.02 |
CSBR Forecast & Estimates
7 analysts have analysed CSBR and the average price target is 12.24 USD. This implies a price increase of 78.69% is expected in the next year compared to the current price of 6.85.
For the next year, analysts expect an EPS growth of -50.13% and a revenue growth 7.8% for CSBR